A novel peptide sansalvamide analogue inhibits pancreatic cancer cell growth through G0/G1 cell-cycle arrest

Keyphrases

• Pancreatic Cancer Cells 100%
• Cancer Cell Growth 100%
• Novel Peptide 100%
• Pancreatic Cancer 100%
• Apoptosis Induction 100%
• G1 Cell Cycle Arrest 100%
• Sansalvamide A 100%
• Human Pancreatic Cancer Cell Line 50%
• Human Pancreatic Cancer Cells 50%
• DNA Synthesis 50%
• Concentration-dependent 50%
• Apoptosis 50%
• Morphological Changes 50%
• Cell Proliferation 50%
• AsPC-1 50%
• G1 Phase 50%
• Cyclic Peptide 50%
• Induced Apoptosis 50%
• Cell Cycle Phases 50%
• Annexin V Binding 50%
• Effective Therapy 50%
• Marine Fungi 50%
• G1 Arrest 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Pancreas Cancer 100%
• Cancer Growth 100%
• Lipocortin 5 16%
• Cyclodepsipeptide 16%